Sequana Medical NV (FRA:2SE) Total Assets: €14.57 Mil (As of Jun. 2025)


FRA:2SE Sequana Medical NV FRA:2SE
31 GF Score
Price €0.51
GF Value €0.19
! 12 Warning Signs
View Full Analysis

What is Sequana Medical NV Total Assets?

Sequana Medical NV FRA:2SE 31 Total Assets is €14.57 Mil as of Jun. 2025. GuruFocus rates FRA:2SE with a GF Score™ of 31/100 and a GF Value™ of €0.19. The stock has 12 warning signs investors should review.

Sequana Medical NV's Total Assets for the quarter that ended in Jun. 2025 was €14.57 Mil.

During the past 12 months, Sequana Medical NV's average Total Assets Growth Rate was 9.40% per year. During the past 3 years, the average Total Assets Growth Rate was 6.30% per year. During the past 5 years, the average Total Assets Growth Rate was 16.50% per year. During the past 10 years, the average Total Assets Growth Rate was 13.80% per year.

During the past 11 years, Sequana Medical NV's highest 3-Year average Total Assets Growth Rate was 36.10%. The lowest was -14.70%. And the median was 14.00%.

Total Assets is connected with ROA %. Sequana Medical NV's annualized ROA % for the quarter that ended in Jun. 2025 was -298.23%. Total Assets is also linked to Revenue through Asset Turnover. Sequana Medical NV's Asset Turnover for the quarter that ended in Jun. 2025 was 0.00.

Sequana Medical NV  (FRA:2SE) Total Assets Explanation

Total Assets is connected with ROA %.

Sequana Medical NV's annualized ROA % for the quarter that ended in Jun. 2025 is

ROA %=Net Income (Q: Jun. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Jun. 2025 ))/ count )
=-36.556/( (9.944+14.571)/ 2 )
=-36.556/12.2575
=-298.23 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sequana Medical NV's Asset Turnover for the quarter that ended in Jun. 2025 is

Asset Turnover
=Revenue (Q: Jun. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Jun. 2025 ))/ count )
=0/( (9.944+14.571)/ 2 )
=0/12.2575
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sequana Medical NV Total Assets Related Terms

Sequana Medical NV Total Assets Historical Data

* Premium members only.

The historical data trend for Sequana Medical NV's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequana Medical NV Total Assets Chart

Sequana Medical NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.21 14.71 26.03 10.10 9.94

Sequana Medical NV Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.13 10.10 10.79 9.94 14.57
FRA:2SE
31GF Score
Sequana Medical NV FRA:2SE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sequana Medical NV Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sequana Medical NV's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-44.379+54.323
=9.94

Sequana Medical NV's Total Assets for the quarter that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (Q: Jun. 2025 )+Total Liabilities (Q: Jun. 2025 )
=-39.175+53.746
=14.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €14.57 Mil mean?
Sequana Medical NV (FRA:2SE) has a Total Assets of €14.57 Mil as of Jun. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Sequana Medical NV and its competitors.
Is Sequana Medical NV's Total Assets too high?
Sequana Medical NV's current Total Assets is €14.57 Mil. Overall, Sequana Medical NV has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's Total Assets compare to ABT and SYK?
Sequana Medical NV's Total Assets of €14.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Sequana Medical NV and its competitors. Sequana Medical NV's current Total Assets is €14.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Sequana Medical NV (FRA:2SE) has a current Total Assets of €14.57 Mil. The stock's GF Value™ is €0.19, compared to a current price of €0.51 — trading 169.5% above its estimated fair value. The current Total Assets is €14.57 Mil. Sequana Medical NV's overall GF Score™ is 31/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Sequana Medical NV (FRA:2SE), the current Total Assets is €14.57 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sequana Medical NV (FRA:2SE) Overvalued in 2026?

Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued. The current stock price of €0.51 is trading 169.5% above its estimated GF Value™ of €0.19.

Key valuation signals for FRA:2SE:

  • Total Assets: €14.57 Mil
  • GF Value™: €0.19 vs. price of €0.51 (169.5% above fair value)
  • GF Score™: 31/100 with 12 warning signs

No single metric tells the full story. See the FRA:2SE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sequana Medical NV Business Description

Other Exchanges 2SE:GermanySEQUA:Belgium
Address Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
31GF Score

Get the complete analysis for FRA:2SE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price
€0.19
GF Value